Position of immunological techniques in screening in clinical toxicology.
about
Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.Clinical value of drugs of abuse point of care testing in an emergency department setting.
P2860
Position of immunological techniques in screening in clinical toxicology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Position of immunological techniques in screening in clinical toxicology.
@ast
Position of immunological techniques in screening in clinical toxicology.
@en
type
label
Position of immunological techniques in screening in clinical toxicology.
@ast
Position of immunological techniques in screening in clinical toxicology.
@en
prefLabel
Position of immunological techniques in screening in clinical toxicology.
@ast
Position of immunological techniques in screening in clinical toxicology.
@en
P2860
P356
P1476
Position of immunological techniques in screening in clinical toxicology.
@en
P2093
Steve George
P2860
P304
P356
10.1515/CCLM.2004.249
P577
2004-01-01T00:00:00Z